サマリー

血液グループ分け試薬の世界市場 2023-2027
血液グループ分け試薬市場は、2022年から2027年にかけて4億5695万米ドルの成長が予測され、予測期間中のCAGRは7.73%で加速すると予測されます。この調査レポートは、血液グループ分け試薬市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題を掲載し、約25のベンダーを網羅したベンダー分析も掲載しています。
現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、慢性疾患の有病率の増加、献血の増加、輸血と血液型タイピングの需要の増加によって牽引されています。
Technavioの血液型検査試薬市場は以下のように区分されます：
エンドユーザー別
- 病院および血液銀行
- 臨床検査室
- 学術・研究機関
手法別
- PCR法とマイクロアレイ法
- アッセイベース技術
- 超並列シーケンス技術
- 血清学
地域別
- 北米
- ヨーロッパ
- アジア
- その他の地域（ROW）
本調査では、ソーシャルメディアマーケティングの出現が、今後数年間の血液型分類試薬市場の成長を促進する主要な理由の1つであると特定している。また、技術の進歩や医療施設の普及が進むことで、市場には大きな需要が見込まれます。
当レポートでは、血液型分類試薬市場について以下の分野をカバーしています：
- 血液凝集試薬市場のサイジング
- 血液凝集試薬市場予測
- 血液凝集試薬市場の産業分析
堅牢なベンダー分析は、顧客が市場での地位を向上させるのに役立つように設計されており、これに伴い、本レポートでは、Alpha Laboratories、Arena Bio Scien、Atlas Medical GmbH、AXO Science、BAG Diagnostics GmbH、Bio Rad Laboratories Inc、Danaher Corp.、DIAGAST SAS、Grifols SA、Haemokinesis Ltd.、Merck KGaA、Mesa Laboratories Inc.、Novacyt SA、QuidelOrtho Corp.、Quotient Ltd.、Rapid Labs Ltd.、Torax Biosciences Ltd.、Tulip Diagnostics Pvt.Ltd.、Werfenlife SA、Calibre Scientific Inc.などである。また、血液型分類試薬市場分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/blood-grouping-reagents-market-industry-analysis をご覧ください。
当出版社では、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、要約する方法で、市場の詳細なイメージを提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Technique
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global blood-grouping reagents m 2017 - 2021
o Exhibit 18: Historic Market Size - Data Table on global blood-grouping reagents m 2017 - 2021 ($ million)
o 4.2 End-User Segment Analysis 2017 - 2021
o Exhibit 19: Historic Market Size - End-User Segment 2017 - 2021 ($ million)
o 4.3 Technique Segment Analysis 2017 - 2021
o Exhibit 20: Historic Market Size - Technique Segment 2017 - 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 - 2021
o Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
o 4.5 Country Segment Analysis 2017 - 2021
o Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
• 6 Market Segmentation by End-user
o 6.1 Market segments
o Exhibit 30: Chart on End-user - Market share 2022-2027 (%)
o Exhibit 31: Data Table on End-user - Market share 2022-2027 (%)
o 6.2 Comparison by End-user
o Exhibit 32: Chart on Comparison by End-user
o Exhibit 33: Data Table on Comparison by End-user
o 6.3 Hospitals and blood banks - Market size and forecast 2022-2027
o Exhibit 34: Chart on Hospitals and blood banks - Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Hospitals and blood banks - Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Hospitals and blood banks - Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Hospitals and blood banks - Year-over-year growth 2022-2027 (%)
o 6.4 Clinical laboratories - Market size and forecast 2022-2027
o Exhibit 38: Chart on Clinical laboratories - Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Clinical laboratories - Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Clinical laboratories - Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Clinical laboratories - Year-over-year growth 2022-2027 (%)
o 6.5 Academic and research institutes - Market size and forecast 2022-2027
o Exhibit 42: Chart on Academic and research institutes - Market size and forecast 2022-2027 ($ million)
o Exhibit 43: Data Table on Academic and research institutes - Market size and forecast 2022-2027 ($ million)
o Exhibit 44: Chart on Academic and research institutes - Year-over-year growth 2022-2027 (%)
o Exhibit 45: Data Table on Academic and research institutes - Year-over-year growth 2022-2027 (%)
o 6.6 Market opportunity by End-user
o Exhibit 46: Market opportunity by End-user ($ million)
o Exhibit 47: Data Table on Market opportunity by End-user ($ million)
• 7 Market Segmentation by Technique
o 7.1 Market segments
o Exhibit 48: Chart on Technique - Market share 2022-2027 (%)
o Exhibit 49: Data Table on Technique - Market share 2022-2027 (%)
o 7.2 Comparison by Technique
o Exhibit 50: Chart on Comparison by Technique
o Exhibit 51: Data Table on Comparison by Technique
o 7.3 PCR-based and microarray techniques - Market size and forecast 2022-2027
o Exhibit 52: Chart on PCR-based and microarray techniques - Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Data Table on PCR-based and microarray techniques - Market size and forecast 2022-2027 ($ million)
o Exhibit 54: Chart on PCR-based and microarray techniques - Year-over-year growth 2022-2027 (%)
o Exhibit 55: Data Table on PCR-based and microarray techniques - Year-over-year growth 2022-2027 (%)
o 7.4 Assay-based techniques - Market size and forecast 2022-2027
o Exhibit 56: Chart on Assay-based techniques - Market size and forecast 2022-2027 ($ million)
o Exhibit 57: Data Table on Assay-based techniques - Market size and forecast 2022-2027 ($ million)
o Exhibit 58: Chart on Assay-based techniques - Year-over-year growth 2022-2027 (%)
o Exhibit 59: Data Table on Assay-based techniques - Year-over-year growth 2022-2027 (%)
o 7.5 Massively parallel sequencing techniques - Market size and forecast 2022-2027
o Exhibit 60: Chart on Massively parallel sequencing techniques - Market size and forecast 2022-2027 ($ million)
o Exhibit 61: Data Table on Massively parallel sequencing techniques - Market size and forecast 2022-2027 ($ million)
o Exhibit 62: Chart on Massively parallel sequencing techniques - Year-over-year growth 2022-2027 (%)
o Exhibit 63: Data Table on Massively parallel sequencing techniques - Year-over-year growth 2022-2027 (%)
o 7.6 Serology - Market size and forecast 2022-2027
o Exhibit 64: Chart on Serology - Market size and forecast 2022-2027 ($ million)
o Exhibit 65: Data Table on Serology - Market size and forecast 2022-2027 ($ million)
o Exhibit 66: Chart on Serology - Year-over-year growth 2022-2027 (%)
o Exhibit 67: Data Table on Serology - Year-over-year growth 2022-2027 (%)
o 7.7 Market opportunity by Technique
o Exhibit 68: Market opportunity by Technique ($ million)
o Exhibit 69: Data Table on Market opportunity by Technique ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 71: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 72: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 73: Chart on Geographic comparison
o Exhibit 74: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2022-2027
o Exhibit 75: Chart on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 76: Data Table on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 77: Chart on North America - Year-over-year growth 2022-2027 (%)
o Exhibit 78: Data Table on North America - Year-over-year growth 2022-2027 (%)
o 9.4 Europe - Market size and forecast 2022-2027
o Exhibit 79: Chart on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 80: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 81: Chart on Europe - Year-over-year growth 2022-2027 (%)
o Exhibit 82: Data Table on Europe - Year-over-year growth 2022-2027 (%)
o 9.5 Asia - Market size and forecast 2022-2027
o Exhibit 83: Chart on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 84: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 85: Chart on Asia - Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on Asia - Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
o Exhibit 87: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 88: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 89: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o 9.7 US - Market size and forecast 2022-2027
o Exhibit 91: Chart on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 92: Data Table on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 93: Chart on US - Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on US - Year-over-year growth 2022-2027 (%)
o 9.8 UK - Market size and forecast 2022-2027
o Exhibit 95: Chart on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 96: Data Table on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 97: Chart on UK - Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on UK - Year-over-year growth 2022-2027 (%)
o 9.9 Canada - Market size and forecast 2022-2027
o Exhibit 99: Chart on Canada - Market size and forecast 2022-2027 ($ million)
o Exhibit 100: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
o Exhibit 101: Chart on Canada - Year-over-year growth 2022-2027 (%)
o Exhibit 102: Data Table on Canada - Year-over-year growth 2022-2027 (%)
o 9.10 France - Market size and forecast 2022-2027
o Exhibit 103: Chart on France - Market size and forecast 2022-2027 ($ million)
o Exhibit 104: Data Table on France - Market size and forecast 2022-2027 ($ million)
o Exhibit 105: Chart on France - Year-over-year growth 2022-2027 (%)
o Exhibit 106: Data Table on France - Year-over-year growth 2022-2027 (%)
o 9.11 Japan - Market size and forecast 2022-2027
o Exhibit 107: Chart on Japan - Market size and forecast 2022-2027 ($ million)
o Exhibit 108: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
o Exhibit 109: Chart on Japan - Year-over-year growth 2022-2027 (%)
o Exhibit 110: Data Table on Japan - Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 111: Market opportunity By Geographical Landscape ($ million)
o Exhibit 112: Data Tables on Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 113: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 114: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 115: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 116: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 117: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 118: Matrix on vendor position and classification
o 12.3 Alpha Laboratories
o Exhibit 119: Alpha Laboratories - Overview
o Exhibit 120: Alpha Laboratories - Product / Service
o Exhibit 121: Alpha Laboratories - Key offerings
o 12.4 Arena Bio Scien
o Exhibit 122: Arena Bio Scien - Overview
o Exhibit 123: Arena Bio Scien - Product / Service
o Exhibit 124: Arena Bio Scien - Key offerings
o 12.5 Atlas Medical GmbH
o Exhibit 125: Atlas Medical GmbH - Overview
o Exhibit 126: Atlas Medical GmbH - Product / Service
o Exhibit 127: Atlas Medical GmbH - Key offerings
o 12.6 Bio Rad Laboratories Inc.
o Exhibit 128: Bio Rad Laboratories Inc. - Overview
o Exhibit 129: Bio Rad Laboratories Inc. - Business segments
o Exhibit 130: Bio Rad Laboratories Inc. - Key news
o Exhibit 131: Bio Rad Laboratories Inc. - Key offerings
o Exhibit 132: Bio Rad Laboratories Inc. - Segment focus
o 12.7 Danaher Corp.
o Exhibit 133: Danaher Corp. - Overview
o Exhibit 134: Danaher Corp. - Business segments
o Exhibit 135: Danaher Corp. - Key news
o Exhibit 136: Danaher Corp. - Key offerings
o Exhibit 137: Danaher Corp. - Segment focus
o 12.8 DIAGAST SAS
o Exhibit 138: DIAGAST SAS - Overview
o Exhibit 139: DIAGAST SAS - Product / Service
o Exhibit 140: DIAGAST SAS - Key offerings
o 12.9 Grifols SA
o Exhibit 141: Grifols SA - Overview
o Exhibit 142: Grifols SA - Business segments
o Exhibit 143: Grifols SA - Key offerings
o Exhibit 144: Grifols SA - Segment focus
o 12.10 Haemokinesis Ltd.
o Exhibit 145: Haemokinesis Ltd. - Overview
o Exhibit 146: Haemokinesis Ltd. - Product / Service
o Exhibit 147: Haemokinesis Ltd. - Key offerings
o 12.11 Merck KGaA
o Exhibit 148: Merck KGaA - Overview
o Exhibit 149: Merck KGaA - Business segments
o Exhibit 150: Merck KGaA - Key news
o Exhibit 151: Merck KGaA - Key offerings
o Exhibit 152: Merck KGaA - Segment focus
o 12.12 Novacyt SA
o Exhibit 153: Novacyt SA - Overview
o Exhibit 154: Novacyt SA - Business segments
o Exhibit 155: Novacyt SA - Key offerings
o Exhibit 156: Novacyt SA - Segment focus
o 12.13 QuidelOrtho Corp.
o Exhibit 157: QuidelOrtho Corp. - Overview
o Exhibit 158: QuidelOrtho Corp. - Product / Service
o Exhibit 159: QuidelOrtho Corp. - Key offerings
o 12.14 Quotient Ltd.
o Exhibit 160: Quotient Ltd. - Overview
o Exhibit 161: Quotient Ltd. - Product / Service
o Exhibit 162: Quotient Ltd. - Key news
o Exhibit 163: Quotient Ltd. - Key offerings
o 12.15 Rapid Labs Ltd.
o Exhibit 164: Rapid Labs Ltd. - Overview
o Exhibit 165: Rapid Labs Ltd. - Product / Service
o Exhibit 166: Rapid Labs Ltd. - Key offerings
o 12.16 Tulip Diagnostics Pvt. Ltd.
o Exhibit 167: Tulip Diagnostics Pvt. Ltd. - Overview
o Exhibit 168: Tulip Diagnostics Pvt. Ltd. - Product / Service
o Exhibit 169: Tulip Diagnostics Pvt. Ltd. - Key offerings
o 12.17 Werfenlife SA
o Exhibit 170: Werfenlife SA - Overview
o Exhibit 171: Werfenlife SA - Product / Service
o Exhibit 172: Werfenlife SA - Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 173: Inclusions checklist
o Exhibit 174: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 175: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 176: Research methodology
o Exhibit 177: Validation techniques employed for market sizing
o Exhibit 178: Information sources
o 13.5 List of abbreviations
o Exhibit 179: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by End-user
Exhibits6: Executive Summary - Chart on Market Segmentation by Technique
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on global blood-grouping reagents m 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - End-User Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - Technique Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on End-user - Market share 2022-2027 (%)
Exhibits31: Data Table on End-user - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by End-user
Exhibits33: Data Table on Comparison by End-user
Exhibits34: Chart on Hospitals and blood banks - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Hospitals and blood banks - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Hospitals and blood banks - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Hospitals and blood banks - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Clinical laboratories - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Clinical laboratories - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Clinical laboratories - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Clinical laboratories - Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Academic and research institutes - Market size and forecast 2022-2027 ($ million)
Exhibits43: Data Table on Academic and research institutes - Market size and forecast 2022-2027 ($ million)
Exhibits44: Chart on Academic and research institutes - Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Academic and research institutes - Year-over-year growth 2022-2027 (%)
Exhibits46: Market opportunity by End-user ($ million)
Exhibits47: Data Table on Market opportunity by End-user ($ million)
Exhibits48: Chart on Technique - Market share 2022-2027 (%)
Exhibits49: Data Table on Technique - Market share 2022-2027 (%)
Exhibits50: Chart on Comparison by Technique
Exhibits51: Data Table on Comparison by Technique
Exhibits52: Chart on PCR-based and microarray techniques - Market size and forecast 2022-2027 ($ million)
Exhibits53: Data Table on PCR-based and microarray techniques - Market size and forecast 2022-2027 ($ million)
Exhibits54: Chart on PCR-based and microarray techniques - Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on PCR-based and microarray techniques - Year-over-year growth 2022-2027 (%)
Exhibits56: Chart on Assay-based techniques - Market size and forecast 2022-2027 ($ million)
Exhibits57: Data Table on Assay-based techniques - Market size and forecast 2022-2027 ($ million)
Exhibits58: Chart on Assay-based techniques - Year-over-year growth 2022-2027 (%)
Exhibits59: Data Table on Assay-based techniques - Year-over-year growth 2022-2027 (%)
Exhibits60: Chart on Massively parallel sequencing techniques - Market size and forecast 2022-2027 ($ million)
Exhibits61: Data Table on Massively parallel sequencing techniques - Market size and forecast 2022-2027 ($ million)
Exhibits62: Chart on Massively parallel sequencing techniques - Year-over-year growth 2022-2027 (%)
Exhibits63: Data Table on Massively parallel sequencing techniques - Year-over-year growth 2022-2027 (%)
Exhibits64: Chart on Serology - Market size and forecast 2022-2027 ($ million)
Exhibits65: Data Table on Serology - Market size and forecast 2022-2027 ($ million)
Exhibits66: Chart on Serology - Year-over-year growth 2022-2027 (%)
Exhibits67: Data Table on Serology - Year-over-year growth 2022-2027 (%)
Exhibits68: Market opportunity by Technique ($ million)
Exhibits69: Data Table on Market opportunity by Technique ($ million)
Exhibits70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits71: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits72: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits73: Chart on Geographic comparison
Exhibits74: Data Table on Geographic comparison
Exhibits75: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits100: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits101: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits103: Chart on France - Market size and forecast 2022-2027 ($ million)
Exhibits104: Data Table on France - Market size and forecast 2022-2027 ($ million)
Exhibits105: Chart on France - Year-over-year growth 2022-2027 (%)
Exhibits106: Data Table on France - Year-over-year growth 2022-2027 (%)
Exhibits107: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits108: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits109: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibits110: Data Table on Japan - Year-over-year growth 2022-2027 (%)
Exhibits111: Market opportunity By Geographical Landscape ($ million)
Exhibits112: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits113: Impact of drivers and challenges in 2022 and 2027
Exhibits114: Overview on Criticality of inputs and Factors of differentiation
Exhibits115: Overview on factors of disruption
Exhibits116: Impact of key risks on business
Exhibits117: Vendors covered
Exhibits118: Matrix on vendor position and classification
Exhibits119: Alpha Laboratories - Overview
Exhibits120: Alpha Laboratories - Product / Service
Exhibits121: Alpha Laboratories - Key offerings
Exhibits122: Arena Bio Scien - Overview
Exhibits123: Arena Bio Scien - Product / Service
Exhibits124: Arena Bio Scien - Key offerings
Exhibits125: Atlas Medical GmbH - Overview
Exhibits126: Atlas Medical GmbH - Product / Service
Exhibits127: Atlas Medical GmbH - Key offerings
Exhibits128: Bio Rad Laboratories Inc. - Overview
Exhibits129: Bio Rad Laboratories Inc. - Business segments
Exhibits130: Bio Rad Laboratories Inc. - Key news
Exhibits131: Bio Rad Laboratories Inc. - Key offerings
Exhibits132: Bio Rad Laboratories Inc. - Segment focus
Exhibits133: Danaher Corp. - Overview
Exhibits134: Danaher Corp. - Business segments
Exhibits135: Danaher Corp. - Key news
Exhibits136: Danaher Corp. - Key offerings
Exhibits137: Danaher Corp. - Segment focus
Exhibits138: DIAGAST SAS - Overview
Exhibits139: DIAGAST SAS - Product / Service
Exhibits140: DIAGAST SAS - Key offerings
Exhibits141: Grifols SA - Overview
Exhibits142: Grifols SA - Business segments
Exhibits143: Grifols SA - Key offerings
Exhibits144: Grifols SA - Segment focus
Exhibits145: Haemokinesis Ltd. - Overview
Exhibits146: Haemokinesis Ltd. - Product / Service
Exhibits147: Haemokinesis Ltd. - Key offerings
Exhibits148: Merck KGaA - Overview
Exhibits149: Merck KGaA - Business segments
Exhibits150: Merck KGaA - Key news
Exhibits151: Merck KGaA - Key offerings
Exhibits152: Merck KGaA - Segment focus
Exhibits153: Novacyt SA - Overview
Exhibits154: Novacyt SA - Business segments
Exhibits155: Novacyt SA - Key offerings
Exhibits156: Novacyt SA - Segment focus
Exhibits157: QuidelOrtho Corp. - Overview
Exhibits158: QuidelOrtho Corp. - Product / Service
Exhibits159: QuidelOrtho Corp. - Key offerings
Exhibits160: Quotient Ltd. - Overview
Exhibits161: Quotient Ltd. - Product / Service
Exhibits162: Quotient Ltd. - Key news
Exhibits163: Quotient Ltd. - Key offerings
Exhibits164: Rapid Labs Ltd. - Overview
Exhibits165: Rapid Labs Ltd. - Product / Service
Exhibits166: Rapid Labs Ltd. - Key offerings
Exhibits167: Tulip Diagnostics Pvt. Ltd. - Overview
Exhibits168: Tulip Diagnostics Pvt. Ltd. - Product / Service
Exhibits169: Tulip Diagnostics Pvt. Ltd. - Key offerings
Exhibits170: Werfenlife SA - Overview
Exhibits171: Werfenlife SA - Product / Service
Exhibits172: Werfenlife SA - Key offerings
Exhibits173: Inclusions checklist
Exhibits174: Exclusions checklist
Exhibits175: Currency conversion rates for US$
Exhibits176: Research methodology
Exhibits177: Validation techniques employed for market sizing
Exhibits178: Information sources
Exhibits179: List of abbreviations